U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Consolidation Manager - IFRS & Group Reporting

Financial AccountingUpdated on Nov 14
Full-timeBrussels, BelgiumNo salary listed

About the Job

Requirements

  • A Master's degree in Finance, Accounting, Business Administration, or a related field.
  • Professional experience applying International Financial Reporting Standards (IFRS), including interpreting complex accounting topics and translating them into practical guidance for a broad range of stakeholders.
  • Relevant experience in technical accounting and Group financial reporting within a complex international environment.
  • Strong analytical, planning, and organizational skills, with close attention to detail and sound professional judgment.
  • A reliable and flexible approach, including adapting priorities and contributing during key reporting periods to meet agreed deadlines while maintaining quality and accuracy.
  • A collaborative and proactive working style, clear English communication, and confidence partnering across functions, geographies, and cultures.
  • Interest in reporting systems, process improvement, and automation.

Responsibilities

  • Provide practical IFRS guidance on complex accounting matters, assess reporting implications, and clearly document conclusions.
  • Monitor relevant IFRS developments and support consistent interpretation and application across the Group.
  • Contribute to half-year financial publications and the financial section of the Integrated Annual Report, helping ensure IFRS-compliant, accurate, and audit-ready disclosures.
  • Review significant financial movements, reporting adjustments, and local submissions, including profit and loss, balance sheet, equity, and cash flow information.
  • Support Group consolidation and closing activities, working with stakeholders to resolve issues and meet reporting timelines.
  • Collaborate with auditors and finance partners while improving reporting procedures, controls, systems, and automation through cross-functional finance initiatives.

Desired Qualifications

  • Hands-on experience with consolidation and closing activities is an advantage.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs